Data-centre leg entering ramp — capex phase in focus
Sterlite expects Q2 momentum to reflect strong order book and data-centre traction. Watch revenue run-rate, mix-shift impact on margins, and the capex outlook as management enters a ₹3,000 Cr expansion cycle.
The Setup
Sterlite Technologies enters Q2 FY-2027 riding momentum from a strong Q1 beat and a cascade of major order wins. Revenue grew 23% YoY to ₹744 Cr in Q1; EBITDA margin held at 21.1%. Since the quarter close, the company has announced a USD 1.2 billion long-term supply agreement with a hyperscaler (valid through Dec 2030), a ₹960 Cr domestic telecom order, and board approval for a ₹3,000 Cr capex programme to expand optical fibre and connectivity manufacturing. The Street consensus has upgraded significantly — Nuvama now targets ₹1,100, CLSA ₹950 — reflecting the AI data-centre thesis. The core question for Q2: does revenue growth accelerate past Q1's run-rate, and what does the early capex cycle do to free cash flow visibility?
~₹800–850 Cr
Q1 was ₹744 Cr; assume 8–14% sequential growth from order momentum
~20–22%
Q1 held 21.1%; watch for data-centre mix headwind (lower-margin orders ramp)
₹3,000+ Cr
USD 1.2B + ₹960 Cr domestic + prior contracts; multi-year runways
₹3,000 Cr approved
Timeline, draw schedule, and FCF impact to be detailed in call
What a Strong vs Weak Print Looks Like
Strong: Revenue breaks ₹850 Cr (15%+ sequential), EBITDA margin stable above 21%, management provides multi-year capex timeline with confidence in order absorption, and data-centre revenue contribution disclosed (tracking 30% target). Weak: Revenue flat or down sequentially (capacity bottlenecks, order delay), margin compresses below 20% (mix or input-cost headwind), capex details sparse or pushed out, or data-centre bookings slow.
On Track?
The company has not issued formal FY27 guidance in public filings available to us; Q1 beat (+23% YoY revenue) suggests management confidence. The ₹3,000 Cr capex and multi-year contract wins (USD 1.2B, ₹960 Cr) are consistent with a growth-phase narrative — capex as a % of revenue will spike and must be justified by near-term order absorption. Management's disclosure of FY29 targets (₹20,000 Cr revenue, implied in recent filings) implies 40%+ CAGR from current run-rate — aggressive but anchored in visible orders. Execution risk: capex ramp requires working-capital discipline and on-time order fulfilment.
Since Last Quarter
Order wins & deals (positive momentum): USD 1.2B hyperscaler LTSA (Sept 2026, corrected filing Aug 29), USD 210M international telecom agreement (Aug 2026), ₹960 Cr domestic telecom order (Aug 2026). All multi-year, high-visibility. Capex & expansion: ₹3,000 Cr capex approved (Sept 2026) for optical fibre and connectivity capacity — signals FY27–FY29 growth phase. Product launches: Neuralis portfolio expansion (plenum-rated assemblies, pre-terminated trunks for AI data centres; Sept 2026) — positioning for hyperscaler specs. ESG & transitions: 100% green power transition announced (Aug 2026). Management: Lakshmi Iyer appointed Chief M&A & IR Officer (Sept 2026) — suggests M&A appetite alongside organic capex. Litigation win: High Court partly allowed writ petition on Kakinada Smart City contract (Aug 2026); won ₹8.56 Cr DoT demand litigation (Aug 2026). Ownership: Motilal Oswal Mutual Fund increased stake to 7.66% via open-market buy (Aug 2026); FII ownership up 1.49pp QoQ to 19.71%. No pledges or insider selling flagged. Routine: Board meeting notice (Oct 23 to consider unaudited results, standard agenda).
1 · Revenue run-rate and sequential momentum
Q1 set ₹744 Cr; expect ₹800–850 Cr as a healthy continuation. Miss would suggest order delays or capacity constraints. Beat signals traction beyond visibility.
2 · EBITDA margin and data-centre mix commentary
Margin hold/improve above 21% is the bull case. Compression signals either input cost pressure or a lower-margin order mix coming through (data-centre orders typically lower-margin initially). Management's disclosure of data-centre % of revenue is critical for FY28–FY29 visibility.
3 · Capex phasing and free cash flow guidance
₹3,000 Cr approved, but draw schedule matters. If ₹500+ Cr spent in FY27, FCF turns negative; must be justified by near-term order conversion. Management confidence in capex ROI and payback horizon will define investor appetite for re-rating.
Sterlite Technologies is in the early stage of a multi-year capex and order-execution cycle, anchored by AI data-centre demand and a global optical connectivity market growing 21% CAGR through 2029. Q1's 23% revenue growth, coupled with USD 1.2B+ in hyperscaler contracts, sets an ambitious bar for Q2. The Street is priced for flawless delivery — margin stability, order absorption, and capex discipline are non-negotiable. Watch for management's tone on data-centre revenue mix, FY28 guidance, and the capex timeline; a vague or deferred capex roadmap will invite profit-taking from the current levels near ATH.
Informational and educational content only. Not investment advice.